ReviewJournal of translational medicine2025

From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy.

E Pinto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.